BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 401613)

  • 1. Effect of o-(beta-hydroxyethyl)-rutoside in lymphangiography.
    Broks PD
    AJR Am J Roentgenol; 1977 Feb; 128(2):263-5. PubMed ID: 401613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tri- and tetra-O-(beta-hydroxyethyl)-rutoside on red blood cell aggregation of human blood.
    van Haeringen NJ
    Bibl Anat; 1975; 13():197-9. PubMed ID: 1231726
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of O-(beta-hydroxyethyl)-rutoside (HR) on macromolecular leakage, thrombosis and haemostasis in experimental animals.
    Bergqvist D; Svensjö E; Arfors KE
    Ups J Med Sci; 1978; 83(2):123-7. PubMed ID: 664118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of O-(beta-hydroxyethyl)-rutoside on wound healing in the rat.
    Wilhelmi G
    Pharmacology; 1979; 19(2):82-5. PubMed ID: 531085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of the flavonoid O-(beta-hydroxyethyl)-rutoside on increased microvascular permeability induced by various agents in rat skin.
    Gerdin B; Svensjö E
    Int J Microcirc Clin Exp; 1983; 2(1):39-46. PubMed ID: 6088413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
    Hackett AM; Griffiths LA; Luyckx AS; van Cauwenberge H
    Arzneimittelforschung; 1976; 26(5):925-8. PubMed ID: 989368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the activity of a flavonoid, 3-(beta-hydroxyethyl)-rutoside, at high dose levels on venous tone measured by "strain gauge" plethylsmography.
    Forconi S; Guerrini M; Di Perri T
    Vasa; 1977; 6(3):279-84. PubMed ID: 335696
    [No Abstract]   [Full Text] [Related]  

  • 8. o-(beta-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment.
    Bull JM; Strebel FR; Sunderland BA; Bulger RE; Edwards M; Siddik ZH; Newman RA
    Cancer Res; 1988 Apr; 48(8):2239-44. PubMed ID: 3349489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation and inhibition of biosynthesis of prostaglandins in human skin by some hydroxyethylated rutosides.
    Arturson G; Jonsson CE
    Prostaglandins; 1975 Dec; 10(6):941-8. PubMed ID: 1208886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of O-(beta-hydroxyethyl)-rutoside (venoruton) on the adherence of leukocytes in patients with arteriosclerosis obliterans of the lower limbs].
    Lukjan H; Szpak A; Bodzenta A; Bielawiec M; Rosc D; Chyzy R
    Pol Arch Med Wewn; 1985 Jun; 73(6):345-50. PubMed ID: 3880372
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of O-(beta-hydroxyethyl)-rutoside on the glucose metabolism of cultured human varicose saphenous veins.
    Matagne D; Gilles R
    Arch Int Physiol Biochim; 1977 Feb; 85(1):133-8. PubMed ID: 68718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic effect of O-(beta-hydroxy ethyl)rutoside in mice.
    Ramaswamy S; Pillai NP; Gopalakrishnan V; Parmar NS; Ghosh MN
    Indian J Exp Biol; 1985 Apr; 23(4):219-20. PubMed ID: 4077117
    [No Abstract]   [Full Text] [Related]  

  • 13. [A 3-month, randomized double-blind dose-response study with 0-(beta-hydroxyethyl)-rutoside oral solutions].
    Nocker W; Diebschlag W; Lehmacher W
    Vasa; 1989; 18(3):235-8. PubMed ID: 2678805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-(beta-hydroxyethyl)-rutoside (Venoruton) fails to block histamine or bradykinin-induced edema formation in the canine forelimb perfused at constant arterial inflow.
    Dobbins DE; Soika CY; Dabney JM
    Microcirc Endothelium Lymphatics; 1984 Oct; 1(5):509-23. PubMed ID: 6546155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside].
    Agolini G; Cavallini GM
    Clin Ter; 1987 Jan; 120(2):101-10. PubMed ID: 2972438
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective effects of O-(beta-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat.
    Dobyan DC; Bull JM; Strebel FR; Sunderland BA; Bulger RE
    Lab Invest; 1986 Nov; 55(5):557-63. PubMed ID: 3773477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect ofO-(beta-hydroxyethyl)rutoside on intestinal tract cells following partial body irradiation].
    Oberhausen H
    Arzneimittelforschung; 1975 Jan; 25(1):101-5. PubMed ID: 1173762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Venoruton on the factor XIII activity in rat plasma.
    Grochal M; Sempińska-Edelberg E; Plewiński J
    Pol J Pharmacol Pharm; 1978; 30(5):659-63. PubMed ID: 751007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histochemical and ultrastructural studies on the anti-edema and radiation-protective effects of 0-(beta-hydroxyethyl)-rutosides in the rat brain after single-dose irradiation. 1. Electron microscopy study of terminal blood circulation].
    Thiel HJ; Hammersen F; Sauer R
    Strahlenther Onkol; 1988 Sep; 164(9):544-52. PubMed ID: 3175854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contrast retention in retroperitoneal lymph nodes after lymphography; the effect of lymph node abnormalities, radiotherapy and contrast quantity].
    Sauer R
    Rofo; 1975 Jan; 122(1):10-4. PubMed ID: 122951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.